InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (27 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
27
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Doshi Dipal. Officer active across 2 companies, notably Entrada Therapeutics, Inc.. In total, 40 reports have been logged. Split: 0 buy · 27 sells. Total volume traded: €618k. Activity tracked since 13 January 2022. The latest transaction was disclosed on 1 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Doshi Dipal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
139,400 shares0Common StockSEC:0001613084-26-000001:0
5,663 shares@ US$27.8539.6% of flowCommonSEC:0001193125-26-041482:0
8,723 shares@ US$5.43025.8% of flowCommon StockSEC:0001613084-25-000003:0
116,200 shares0Common StockSEC:0001689375-25-000015:0
4,040 shares@ US$52.32100.0% of flowCommonSEC:0000950170-25-017892:0
2,328 shares@ US$15.76114.9% of flowCommon StockSEC:0001689375-24-000052:0
300 shares@ US$18.000.7% of flowCommon StockSEC:0001689375-24-000040:0
1,000 shares@ US$16.17362.2% of flowCommon StockSEC:0001689375-24-000033:0
1,800 shares@ US$15.003.6% of flowCommon StockSEC:0001689375-24-000030:0
104,700 shares0Common StockSEC:0001689375-24-000006:0
1,000 shares@ US$15.002.1% of flowCommon StockSEC:0001689375-24-000002:0
1,000 shares@ US$15.992.1% of flowCommon StockSEC:0001689375-24-000001:0
1,000 shares@ US$15.002.0% of flowCommon StockSEC:0001689375-23-000076:0
1,000 shares@ US$16.232.2% of flowCommon StockSEC:0001689375-23-000075:0
1,000 shares@ US$15.002.1% of flowCommon StockSEC:0001689375-23-000069:0
1,000 shares@ US$15.002.5% of flowCommon StockSEC:0001689375-23-000066:0
49,650 shares0Common StockSEC:0001689375-23-000065:0
1,000 shares@ US$15.67132.1% of flowCommon StockSEC:0001689375-23-000056:0
2,000 shares@ US$13.71093.6% of flowCommon StockSEC:0001689375-23-000033:0
2,092 shares@ US$18.00925.1% of flowCommon StockSEC:0001689375-23-000032:0
49,650 shares0Common StockSEC:0001689375-23-000030:0
1,800 shares@ US$14.62963.6% of flowCommon StockSEC:0001689375-23-000020:0
99,300 shares0Common StockSEC:0001689375-23-000013:0
2,000 shares@ US$12.003.3% of flowCommon StockSEC:0001689375-23-000009:0
2,000 shares@ US$12.00053.2% of flowCommon StockSEC:0001689375-23-000005:0
25 of 40 declarations
About Doshi Dipal
Doshi Dipal is a declarant linked to Entrada Therapeutics, Inc. as CEO and to Azenta, Inc. as Director. The file shows 40 filings in total, and the 40 sampled filings, from 2022-01-18 to 2026-03-03, show EUR 617571 of sales and EUR 0 of purchases, with the transaction nature listed as Cession.
